Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Ondansetron × 1 year × Clear all

Sponsor

Conditions

Vomiting 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Postoperative Nausea and Vomiting 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Gynecologic Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

lutetium Lu 177 dotatate 18 Magnetic Resonance Spectroscopy 10 Everolimus 8 pembrolizumab 7 Specimen Handling 7 Nivolumab 6 Capecitabine 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 surufatinib 4 cabozantinib 4 amino-acid, glucose, and electrolyte solution 4 Octreotide 4 lenvatinib 3 gallium Ga 68 dotatate 3 Temozolomide 3 Ipilimumab 3 Injections 3 Fluorodeoxyglucose F18 3 Cyclophosphamide 3 tislelizumab 2 olaparib 2 lanreotide 2 fludarabine phosphate 2 fludarabine 2 atezolizumab 2 X-Rays 2 Surveys and Questionnaires 2 Phantoms, Imaging 2 PM 01183 2 FAPI-46 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡